by News Feed Editor | Jun 1, 2026 | COVID-19
FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure MedPage Today Article Attribution | Read More at Article Source
by News Feed Editor | Jun 1, 2026 | COVID-19
Shionogi’s COVID antiviral Xocova passes muster with FDA as post-exposure preventative Fierce Pharma Article Attribution | Read More at Article Source
by News Feed Editor | Jun 1, 2026 | COVID-19
US regulator approves oral drug from Japan’s Shionogi to prevent COVID-19 Reuters Article Attribution | Read More at Article Source
by News Feed Editor | Jun 1, 2026 | COVID-19
FDA Approves Ensitrelvir as First Oral Post-Exposure Prevention Option for COVID-19 Contagion Live Article Attribution | Read More at Article Source
by News Feed Editor | Jun 1, 2026 | COVID-19
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 Drug Topics Article Attribution | Read More at Article Source
by News Feed Editor | Jun 1, 2026 | COVID-19
(ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure Business Wire Article Attribution | Read More at Article Source